Sunzen Biotech Bhd (0148) — Cash Flow Reinvestment Rate
Sunzen Biotech Bhd (0148) has a Cash Flow Reinvestment Rate of 0.04x as of September 2023, reinvesting RM145.00K (capex RM95.00K plus investments RM50.00K) from operating cash flow of RM3.58 Million. Explore Sunzen Biotech Bhd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sunzen Biotech Bhd Cash Flow Reinvestment Rate (2016–2023)
Historical reinvestment intensity for Sunzen Biotech Bhd across 4 annual periods. Also explore Sunzen Biotech Bhd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sunzen Biotech Bhd (2016–2023)
Year-by-year capital reinvestment analysis for Sunzen Biotech Bhd. For live market cap and broader valuation context, see 0148 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 2.96x | RM2.43 Million | RM819.39K | RM1.01 Million | ▲ +1495.8% |
| 2020 | 0.19x | RM1.34 Million | RM7.20 Million | RM1.16 Million | ▼ -87.5% |
| 2017 | 1.49x | RM5.98 Million | RM4.02 Million | RM3.42 Million | ▼ -95.7% |
| 2016 | 34.76x | RM8.90 Million | RM256.13K | RM6.64 Million | — |